| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 8,541,261 | 7,672,329 | 5,969,741 | | Cost of Revenue | 2,228,069 | 1,762,972 | 1,256,792 | | | Gross Profit | 6,313,192 | 5,909,357 | 4,712,949 | | | Operating Expenses | | Research Development | 725,600 | 619,727 | 494,695 | | Selling General and Administrative | 2,880,422 | 3,081,408 | 2,598,220 | | Non Recurring | 49,119 | 1,390,938 |
-
| | Others | 582,369 | 204,104 | 197,078 | | | | Total Operating Expenses | 4,237,510 | 5,296,177 |
-
| | | | Operating Income or Loss | 2,075,682 | 613,180 | 1,422,956 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 115,919 | 154,271 | 130,021 | | Earnings Before Interest And Taxes | 2,191,601 | 767,451 | 1,552,977 | | Interest Expense | 8,037 | 16,600 | 5,916 | | Income Before Tax | 2,183,564 | 750,851 | 1,547,061 | | Income Tax Expense | 404,090 | 402,600 | 421,418 | | Minority Interest |
-
|
-
| (4) | | | | Net Income From Continuing Ops | 1,779,474 | 348,251 | 1,125,639 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,779,474 | 348,251 | 1,125,639 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,779,474 | $348,251 | $1,125,639 |
|
0.16% Nasdaq 
0.085 (0.36%) 
Income Statement
